Open Access to DEL for data sharing – DELopen
DELopen platform is dedicated to the development and application of DEL technology in drug discovery. Free access to DEL, data...
Continue ReadingKnowledge Library
DEL Screening – DELight Handbook
DEL Screening | WuXi AppTec DELight Kit Faster and Lighter Drug Discovery DELight kit containing 58 libraries and 10.8 billion...
Continue Reading Translational Oncology
Biomarker discovery Mouse clinical trial 61 PDX-derived primary cancer cell lines Drug-resistant xenograft models Combination therapy platform including radiation World...
Continue Reading Patient-Derived Xenograft (PDX) Tumor Models
One of the largest collection of Patient-Derived Xenograft (PDX) Tumor Models in Asia with gene expression/mutation profiling 1200 PDX models...
Continue Reading Immuno-Oncology Services
Immuno-oncology Platform An outstanding platform to enable cancer immunotherapy with one stop service: Immunological function assessment TIL analysis – Flowcytometry,...
Continue Reading Cell Line-Derived Xenograft (CDX) Tumor Models
A large collection of cell line-derived xenograft (CDX) tumor models 215 validated models, SOC data available World leading imaging based...
Continue Reading Virology and Viral Vector Platforms
WuXi virology platforms: Immunology, Anti viral, Viral Vector, Oligo-nucleotide, Clinical and Immunology in vitro screening and profiling in vivo efficacy...
Continue Reading WuXi AppTec in vitro Safety Pharmacology Profiling
Comprehensive in vitro off-target screening services Safety-related drug failure is a major challenge for the pharmaceutical industry. Approximately 75% of...
Continue Reading In Vitro Toxicity Services
Identify Potential Liability Issues in the Early Stages of Drug Discovery Drug-induced toxicity is a primary cause of failure for...
Continue Reading